632

M. D. HANIGAN ET AL.
Metabolic faecal models were completely different, each of the models contains components that can and should be drawn upon in the process of building application models for use by the animal industry. The objective of the present paper is to review some different approaches of modelling protein metabolism. The review will be restricted to post-absorptive protein metabolism in ruminants. The following are selected examples of the various models and some key concepts related to protein metabolism.
THE CORNELL NET CARBOHYDRATE AND PROTEIN SYSTEM
The CNCPS model Russell et al. 1992; Sniffen et al. 1992 ; O'Connor et al. 1993) was constructed for use on-farm by animal nutritionists, to predict nutrient requirements and animal performance. As such, the model is aggregated at the wholeanimal level and considers animal energetics and protein metabolism. The model is unique in that it is the only whole-animal model to include descriptions of both energetics and amino acid (AA) metabolism in ruminating animals.
The critical elements of post-absorptive AA metabolism of the CNCPS are presented in Fig. 1 . The overall post-absorptive system was adopted from National Research Council (1985) with AA descriptions added by O'Connor et al. (1993) . The CNCPS model attempts to segregate post-absorptive protein and AA metabolism into discrete functions. However, these apparently discrete functions are actually empirical relationships based largely on whole-animal observations as presented by National Research Council (1985) . AA utilization in the post-absorptive portion of the model was grouped into four categories: (a) maintenance, (b) tissue accretion, (c) lactation, (d) gestation. 
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AA requirements for maintenance were based on the protein requirements by use for scurf, loss in urine, and metabolic faecal losses, as presented by National Research Council (1 985). These are a function of the body weight (BW), indigestible DM intake, the assumed AA composition of maintenance protein, and the efficiencies of utilization of AA for maintenance (EAAM) . EAAM was set to 0.66 for branched-chain amino acids (BCAA) and 0.85 for the remaining essential amino acids (EAA). Therefore, the efficiency of utilization of the BCAA for maintenance is equivalent to previous values (0.67) used for some metabolizable protein systems (National Research Council, 1985; Tamminga et al. 1994) , while that of the remaining EAA is higher; but both were lower than the value applied in the UK system (1.0; Agricultural and Food Research Council, 1992) .
Requirements for growth were represented as a function of the empty-body gain (EBG; calculated from National Research Council, 1985) , the protein content of EBG, the EAA composition of tissue protein, and the efficiency of use of EAA for growth processes (EAAG). EAAG was assumed to vary with stage of growth and calculated as a function of the relative BW (RBW). The RBW is calculated by adjusting the actual BW to the BW of a National Research Council (1 984) medium-framed steer of equal body composition . For steers, assuming a frame score of 5 at 240 kg BW, EAAG values calculated in this way (0.59) compare favourably with observed values (0.58 for hindlimb fluxes; Boisclair et al. 1993) . However, if adjustment factors for heifers are applied to mature cows, EAAG would become negative in some situations and calculated AA catabolization is not in line with calculated urinary protein losses.
EAA requirements for lactation were a function of milk true-protein yield (calculated from Fox et al. 1992) , the EAA content of milk true protein (adopted from Waghorn & Baldwin, 1984) , and the efficiencies of use of individual EAA for lactation (EAAL). EAAL ranges from a low of 0.42 (arginine) to 1 .O (phenylalanine), adopted from Oldham (1980) and Evans & Patterson (1985) . However, EAA uptake and utilization by the mammary gland has been observed to be variable (Metcalf et al. 1994 . A similar approach was taken for predicting the EAA requirements for conceptus and gravid uterine growth in the pregnant animal with efficiencies of conversion ranging from 0.66 for BCAA and arginine to 0.85 for the remaining EAA.
Summation of these processes for each AA then gives the total use of that AA and thereby the requirement. Whole-animal in vivo measurements including BW and wholebody protein synthesis can be employed to parametrize and evaluate the model. However, maintenance and growth descriptions contain components of multiple tissue beds and, therefore, cannot be derived from arterio-venous concentration (A-V) difference data, except through extensive use of assumptions and conversion of data. Although lactation and gestation are defined as discrete processes and, therefore, can be fitted to data (typically blood flow and AA concentrations), the form of the equations does not allow for direct application. Also, the design of the model and the form of the equations do not allow for explicit representation of AA requirements for non-protein synthesis purposes, notably gluconeogenesis, or for substrate interactions.
BALDWIN ET AL. (1987) MODEL
The model of Baldwin et al. (1987) is also aggregated at the whole-animal level and considers animal energetics and protein metabolism. The model was developed to evaluate current concepts and data for probable adequacy as explanations of variations in nutrient partitioning in lactating cows, and constructed utilizing dynamic relationships allowing integration over time. Three tissue beds were explicitly considered: lean body, adipose and viscera. Consideration of functions specific to mammary gland and liver were also included in the model. A schematic representation of the protein metabolism components is shown in Fig. 2 . Carbohydrate and lipid classes of metabolites were also considered in this model, permitting the direct integration of protein and energy metabolism.
AA were treated as a single pool. Utilization of AA by lean body and viscera for growth, by mammary gland for milk protein synthesis, and by liver for glucose and for energy production were a function of systemic AA concentration: AA concentration. CGl and CGlo are glucose and reference glucose concentrations respectively and are used as an indicator of hormonal status, in particular, insulin and glucagon. Therefore, an increase in glucose concentrations relative to the reference concentrations results in increases in rates of AA use for protein synthesis in viscera and body and a decline in AA catabolism with no change in rates of milk protein synthesis. The relative magnitude of the changes are a function of the rate-constants in the individual flux equations and the exponent used to scale the glucose ratio. As each of the parameters must be defined, efforts to derive these parameters from data are needed. It is not clear whether current data are adequate to derive these parameters for each of the various tissues represented by the model equations.
Protein degradation in the body and visceral pools (PAA,pbAA and PAA,pvAA respectively) were assumed to be linearly related to protein mass and affected by hormonal status using a similar scheme to that for protein synthesis.
However, the hormonal regulation is reciprocal in that increases in glucose concentrations cause reductions in protein degradation in these two tissues. The addition of a defined AA catabolic flux is a valuable addition compared with the efforts of O'Connor et al. (1993) . Lean body and visceral protein catabolic fluxes were assumed to be homogeneous, which is probably not the case given the variety of tissues that take part in these processes. However, the errors associated with this aggregation have not been quantified. In general, the dynamic approach in this model offers some advantages to the functionbased CNCPS approach: (1) individual tissues are explicitly defined. Although they are highly aggregated, this allows more extensive use of tissue level data to define parameters; (2) the model incorporates the concept of tissue competition for a finite supply of AA; (3) the apparent affinity of tissues for AA can be altered independent of other tissues to more accurately represent observations; (4) the predicted efficiency of utilization of AA is not fixed, but can vary widely, dependent on the dietary conditions, in line with experimental observations. However, the aggregated nature of AA descriptions would not be adequate to simulate reduction in protein synthesis rates brought about by limitations in single EAA such as methionine or phenylalanine.
GERRITS ET AL. (1996) MODEL
Like the model of Baldwin et al. (1987) , the model of Gemts et al. (1996) is aggregated at the whole-animal level. In addition it includes a description of EAA and non-essential AA (NEAA) metabolism at the tissue level, thus offering advantages relative to the CNCPS model when utilizing tissue level data. This research model was developed to obtain insight into the partitioning of nutrients from ingestion through intermediary metabolism to protein, fat and ash accretion in growing preruminant calves. A schematic representation of the protein metabolism components is shown in Fig. 3 .
The body storage pools comprise chemical fat, ash, and four protein pools. Body protein was split up into protein pools from several anatomical tissues: muscle, viscera, bone, and hide. Synthesis of protein was related to energy and AA supply and depends on the concentrations of acetyl-CoA equivalents (AcCoA) and of AA, with equations to describe the transactions similar to those presented for the Baldwin et al. (1987) (1987) model, fractional degradation rates did not vary according to nutritional status. Endogenous urinary N loss, net endogenous protein loss in faeces, and losses of scurf, were modelled as a drain on the AA metabolite pool, the visceral protein pool, and the hide protein pool respectively.
In this model, an improper balance of dietary AA will limit protein synthesis and increase AA catabolism. An AA profile was assigned to each of the body protein pools and to dietary protein, based on various literature references. Then, in a calculation routine performed every iteration, the individual AA supply (AA from diet and from degradation of each body protein pool) and demand (AA for protein synthesis and for inevitable oxidative losses of each AA) were compared. Inevitable losses of AA have been introduced (because potential re-utilization of degraded protein for protein synthesis is always less than 100 %; Simon, 1989) and were assumed to be 2 96 of the AA supplied from diet and from body protein degradation. If the supply of a NEAA is less than that required, the cost of synthesis of that NEAA is calculated, which requires AcCoA for the transformation. If the supply of one (or more) EAA is lower than demand, protein synthesis is calculated based on the supply of the most-limiting EAA, and it is assumed that all the AA supplied in excess are oxidized. In case no EAA is limiting, AA oxidation depends on the general AA concentration, and for simplicity is assumed to occur in the liver. The advantages mentioned for the Baldwin et al. (1987) (1996) . The model was designed to examine the effects of AA supply on whole-animal protein metabolism. Ten tissue beds, adipose, central nervous system (CNS), GIT, heart, kidney, liver, muscle, pancreatic and salivary glands (PSG), reticulo-endothelial system (RES), and skin, were defined explicitly. A schematic representation of this dynamic model is shown in Fig. 4 . The model has a common blood AA pool (QBih) which is a function of inputs and outputs, the rate of change described by:
where dQBlh/dt represents the change in QBlh with respect to time. P B m i and UBIMi represent the release and the removal of AA by the individual tissues and are of the form:
where Kci, Qai, and Kbi represent the rate-constant for release of AA by, the amount of free AA in, and the rate-constant for removal of AA by the ith tissue respectively, and C,, and v B [ represent the concentration of blood AA and the volume of blood. Tissue AA metabolism rate was given as: protein for the ith tissue. The only exceptions to this generalized model are the additional input into the GIT free-AA pool arising from the absorption of dietary and endogenous AA from the gut lumen and a fractional transfer of AA from the gut AA pool directly to the liver AA pool without entry into the common AA pool. Like the Gerrits et al. (1996) model, AA catabolism is treated as a homogenous process, i.e. catabolism only occurs in the liver. However, with individual representations of tissues, one could apply catabolic rates to each individual tissue, as quantified recently , and sum those processes at the level of the liver to quantify total urea output. Gill et al. (1989) have chosen to represent protein catabolism as a function of tissue protein mass and tissue AA availability. Their representation will result in a decline in protein degradation as protein synthesis rates increase, rather than the expected increase in protein catabolism (Jepson et al. 1988; Liu et al. 1995) .
Entry of absorbed AA into the GIT free-AA pool will result in an increase in gut mass (or AA catabolism if it were considered) if supply increases. This concept is not supported by recent data which indicate that AA seem to be utilized primarily from systemic sources as opposed to luminal supplies (MacRae et al. 1997b) .
This model is similar in nature to that of Baldwin et al. (1987) , however it is less aggregated, thereby requiring fewer assumptions when fitted to most in vivo data at the organ or tissue level. Limitations of this model, when attempting to use it as a simulation model outside its original objective, include: (1) AA are defined as a common pool and, therefore, the model cannot be used to examine the effects of one or more limiting AA; (2) a high level of complexity is associated with the large number of tissues that are represented; (3) some manipulation of data and assumptions must be made to utilize some types of in vivo data, i.e. A-V difference data cannot be used directly to derive parameters; (4) mammary metabolism is not considered; (5) metabolites of a non-nitrogenous character are not considered, preventing integration of energy and protein metabolism. However, if limitations 1 and 4 were addressed, this model could possibly be parametrized using existing data. It is not currently known whether such an approach is adequate. Given that protein synthesis can be regulated at both the transcriptional and the translational levels, there are no assurances that this approach will prove adequate.
INTEGRATED TISSUE AND TRACER MODELS
Estimates of protein turnover kinetics in tissues and organs have been obtained by using tracer methods in conjunction with simple compartmental models. The basic model to interpret tracer data in the steady-state is the precursor-product model detailed by Waterlow et al. (1978) . Assuming a system of two pools, i.e. the precursor AA (QM) and the tissue protein pool (Qp), conservation of mass principles in steady-state conditions and using some assumptions yields the simple expression:
where FpAA and FOd represent protein synthesis and AA catabolism respectively, I is the constant rate of infusion of label, and sAA is the specific activity of the precursor pool. This No correction was made for oxidation (FoxAA), and protein synthesis estimates based on tyrosine were approximately 60 % higher than those based on leucine, suggesting the tyrosine estimates include a relatively large oxidation component. The need to measure oxidation rates can be circumvented by introducing some kinetic assumptions into the model and considering the product pool, which will yield the Garlick et al. (1973) equation. This equation has been widely applied to the calculation of protein synthesis rates for various tissues in cattle, and such estimates have been adopted in various whole-animal models (Baldwin et al. 1987; Gerrits et al. 1996) . Further methods have been applied to overcome the problem of direct measurement of precursor specific activity, as reviewed by France et al. (1988) .
Tracer methods and simple compartmental models can yield even more information if supplemented with A-V difference measurements. For example, France et al. (1995) developed such a model to resolve data generated using an in vivo A-V difference preparation of the mammary gland coupled with infusions of ['3C]leucine into the jugular vein of lactating dairy cattle . Application of the model to experimental data indicated milk protein and tissue protein synthesis rates which ranged from 0.61 to 0.69 and 0.13 to 0.37mol leucine/d respectively. AA uptake and efflux estimates could be used to generate estimates of AA removal in whole-animal models. These estimates of protein turnover in individual tissues are vital in whole-animal models, as they will affect the energy fluxes involved in these processes and possibly the AA requirements of the animal (Gerrits et al. 1996) .
FUTURE EFFORTS
Whole-animal models currently available (Baldwin et al. 1987; O'Connor et al. 1993; Gerrits et al. 1996) deal with many of the tissues on an aggregated scale. This is a wholly appropriate choice in that as one moves closer to the level of field application, the complexity of the model must decrease. However, as noted previously, further refinement of these models requires additional knowledge at the tissue level. It can be difficult to make full use of the variety of data sets that have been and are currently being collected at that level when dealing with such an aggregated system. An alternative approach is to build integrated tissue-level models that can make direct use of these data. Such models can then be used, after they have been parametrized and tested, to help derive more aggregated relationships that can be incorporated into the whole-animal models. These tissue-level models of intermediary metabolism, including complete descriptions of AA metabolism, are largely absent. Also, in whole-animal models it is not necessary or desirable to represent every single tissue or organ in detail. The work of Gill et al. (1989) would suggest that based on relative rates of protein synthesis, the RES, PSG, adipose, CNS, heart, and kidney tissues could be aggregated into a single entity representing between 14 and 18 % of the total body synthetic rates for a young non-lactating animal. This aggregation would greatly reduce the effort required to develop tissue models. As measurements of AA fluxes in these varied tissues may prove to be beyond our current technical means, parameter estimates for the other tissues must be defined with minimal errors in order to allow the estimates for this aggregated tissue bed to be derived by difference, i.e. estimates of uptake are calculated from total input and predicted rates of utilization by other tissues.
Key aspects in future efforts to construct models of post-absorptive protein metabolism include: first, the delivery of nutrients to organs and tissues by blood; second, improved descriptions of AA metabolism in all organs and tissues. AA are carried to the various tissues in blood. Calculating AA delivery based on flow and concentration then yields units of mass per time. It has been clearly demonstrated that AA removal by tissues is concentration dependent (Oxender & Christensen, 1963) . If the tissues are net utilizers of AA, then changes in blood flow will result in changes in AA concentrations in the extracellular space (Cant & McBride, 1995; Hanigan et al. 1996) and, thereby, removal by the tissue. However, all models that currently consider AA removal from a blood pool (Waghorn & Baldwin, 1984; Baldwin et al. 1987; Gill et al. 1989; Freetly et al. 1993; Hanigan & Baldwin, 1994) have described AA delivery entirely as a function of arterial AA concentration. Such a description provides the proper units for application to tissue removal but ignores the potential effects of blood flow on AA delivery. Additionally, such an approach prevents direct utilization of A-V difference data for parameter estimation. One could easily adapt current models to consider the effects of changes in blood flow to
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64 1 the various tissues by replacing the current tissue uptake equations with the simple algebraic expression presented by Hanigan et al. (1996) . Although such an adaptation would add some complexity to the models, this additional complexity would be no greater than that required to describe blood flow to the various tissue beds. Such an addition would allow direct utilization of A-V difference data and blood flow data and should provide a more accurate representation of the physiology.
Second, more complete descriptions of AA metabolism are required for all tissues. In particular, the complete lack of a model of GIT metabolism must be addressed in order to make progress at the animal level. Tagari & Bergman (1978) observed extensive utilization of AA by the GIT. More recent observations by MacRae et al. (1977a,b) support the observations of Tagari & Bergman (1978) . However, the isotopic movement observed by MacRae et al. (1997a) indicates that the majority of AA that are catabolized are derived from systemic supplies. Therefore, attempts to model this tissue bed would need to accommodate inputs from arterial supply and luminal absorption and the apparent effects of systemic supply on AA catabolism.
Clearly more complete descriptions of liver and mammary models are required. It would seem that these efforts are now possible given the recent activity by experimenters in the area. Numerous data sets containing measurements of AA flux across these tissues are now becoming available (Cant et al. 1993; Hanigan & Baldwin, 1994; Metcalf et al. 1994 Metcalf et al. , 1996 Lobley et al. 1996) , and some of these data sets are supplemented by isotopic flux measurements . Efforts to model these data should yield valuable insight on the metabolism of all substrates by these tissues. Additionally, the mammary data should be extensive enough to thoroughly test the ability of the simple firstlimiting AA representation of milk protein synthesis. One limitation identified by Freetly et al. (1993) was the inadequate supply of lipid precursors to account for observed free fatty acid oxidation and triacylglycerol synthesis rates in the liver. While this may not have a bearing on AA supply, the potential interaction among C sources and oxidation of AA cannot be ignored. It does not appear that any of the more recent data sets are adequate to address this problem. Another major assumption made by Freetly et al. (1993) was related to the rate of utilization of AA for export protein synthesis. The recent data of Connell et al. (1997) can be utilized to help address this assumption.
A similar effort is required for muscle and skin. The aggregation of these two tissues is obvious from the point that most in vivo measurements of muscle metabolism are taken from the hindlimb which would include both muscle and skin. The data in this area are less extensive, but the recent data of Harris et al. (1992) and Boisclair et al. (1993) will be useful in the modelling effort. However, hindlimb metabolism would include bone protein metabolism as well, and the AA composition and turnover rates of muscle, skin and bone protein can be very different when compared with each other (Simon, 1989) .
A more extensive data base will probably be required for parametrization and evaluation of models at tissue and whole-animal level models. In particular, the current method of operation wherein the modeller is responsible for sequestration of the data from a variety of sources and subsequent organization of the data greatly hampers the progress that can be made. A central repository for data would be very useful from a modelling standpoint in that it would reduce the effort to gather and format data. However, it would still be incumbent upon the modeller to ensure the correct interpretation and accuracy of the data before use.
In summary, a great deal of future effort is required to construct and parametrize tissue models. Although modelling at the tissue level should yield significant long-term results, such an endeavour will probably yield very little tangible improvement at the animal level in the short term. Of course, this presumed progress will only be realized if the tissue level work is extended to the whole-animal models.
